Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-18 12:24 UTC (UTC+2h)

Multiple dose study for MR product in EU [Regulatives / Guidelines]

posted by Mahesh M - India, 2014-09-26 09:53  - Posting: # 13591
Views: 2,538

Dear All,

When multiple dose study is required To demonstration of Bioequivalence between two MR dosage form for EU.
The European guidance line no. 593 to 595 states as follows:

"A multiple dose study is needed unless a single dose study has been performed with the highest strength which has demonstrated that the mean AUC(0-τ) after the first dose covers more than 90% of mean AUC(0-∞) for both test and reference, and consequently a low extent of accumulation is expected".

Please elaborate or simplify the same for better understanding.

Regards

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,383 posts in 3,904 threads, 1,173 registered users;
online 18 (2 registered, 16 guests [including 11 identified bots]).

The art and science of asking questions
is the source of all knowledge.    Thomas Berger

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed